Piper Jaffray Upgrades Infinity Pharmaceutical (INFI) to Overweight
Tweet
Share
E-mailGet Alerts INFI Hot Sheet
Price: $8.99 -3.02%
Rating Summary:
2 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 0 | Down: 0 | New: 0
Rating Summary:
2 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 0 | Down: 0 | New: 0
Join SI Premium – FREE
Piper Jaffray upgraded Infinity Pharmaceutical (NASDAQ: INFI) from Neutral to Overweight. PT raised from $6 to $9.
For more ratings news on Infinity Pharmaceutical click here and for the rating history of Infinity Pharmaceutical click here.
Shares of Infinity Pharmaceutical closed at $5.79 yesterday.
For more ratings news on Infinity Pharmaceutical click here and for the rating history of Infinity Pharmaceutical click here.
Shares of Infinity Pharmaceutical closed at $5.79 yesterday.
Create E-mail Alert Related Categories
UpgradesRelated Entities
Piper JaffraySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
